The EU’s review of the vaccine developed by the University of Oxford and AstraZeneca following an increase in blood clot concerns is an “ongoing process”, a top official has said.

Speaking at a 16 March press conference, European Medicines Agency executive director Emer Cooke said there was “no indication” so far that the AstraZeneca vaccine or any other jab has caused increased incidents of blood clotting.